Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
HRAS Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
HRAS target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, clinical competition, IP and R&D strategy.
Latest Hotspot
8 min read
ARAF Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
ARAF target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, clinical competition, IP and R&D strategy.
Latest Hotspot
8 min read
RAF1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
RAF1 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, clinical competition, IP and R&D strategy.
Latest Hotspot
8 min read
MAP2K2 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
MAP2K2 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, clinical competition, IP and R&D strategy.
Latest Hotspot
8 min read
MAPK14 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
MAPK14 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, clinical competition, IP and R&D strategy.
Latest Hotspot
8 min read
MAPK3 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
MAPK3 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, clinical competition, IP and R&D strategy.
Latest Hotspot
8 min read
ITGB2 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
ITGB2 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Pharma Frontiers
8 min read
CXCR4 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
CXCR4 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Pharma Frontiers
8 min read
EPCAM Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
EPCAM target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Latest Hotspot
8 min read
MUC1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
MUC1 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Latest Hotspot
8 min read
CD40 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
CD40 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Latest Hotspot
8 min read
TNFRSF18 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
TNFRSF18 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.